Quarterly report pursuant to Section 13 or 15(d)


6 Months Ended
Jun. 30, 2014
Stockholders' Equity Note [Abstract]  
The Company is authorized to issue 500,000,000 shares of common stock and 40,000,000 shares of preferred stock.
Series A Convertible Preferred Stock
In connection with the closing of the Share Exchange Agreement, on December 7, 2009 the Company issued 10,000,000 shares of Series A Convertible Preferred Stock with a par value of $0.001 and convertible into 2.5 common shares for every Series A Convertible Preferred. 
Liquidation Preference
The Series A preferred stock shall be entitled to receive out of the assets of the Company, whether from capital or from earnings available for distribution to stockholders, eight times the sum available for common stockholders. All other series of preferred stock is junior to the Series A preferred stock with respect to the payment of dividends and the distribution of assets.
On January 15, 2014, in accordance with terms of the cashless exercise provisions of the warrants, a shareholder exchanged 355,000 warrants with an exercise price of a $1.00 and 604,000 warrants with an exercise price of $0.50 for 468,702 fully vested shares of common stock of the Company.  The transaction was recorded as an increase to common stock and a decrease to Additional Paid-In Capital of $469 based on the cashless exercise provisions of the warrants.
The Company settled a pending lawsuit for past due fees due to a consulting firm in the amount of $41,000.  On January 31, 2014, the parties negotiated a settlement resulting in the issuance of 4,098 fully vested shares of the Company’s common stock valued at $1.22 per share, the market value on the date of the settlement and a cash payment of $15,000.  The transaction resulted in a gain on settlement of approximately $21,000 recorded in Other Income/(expense).
In conjunction with the 2013 Plan, the Company issued 100,000 fully vested shares valued at $137,000 to a firm on February 14, 2014 which sponsored a conference in December 2013. The value was determined based on the market value of the stock on the date of the conference and recorded as an accrued expense and general and administrative expense at December 31, 2013.
Compensation expense related to the issuance of common stock for the three months and six months ended June 30, 2014 and 2013 was $0, $1,070,866, $0 and $1,837,881, respectively.